Anew schedule for The Endocrine Society’s 95th Annual Meeting & Expo brings the addition of exciting new sessions and easier travel plans for attendees. The new plan also incorporates ample time in the afternoon and evenings for exploring San Francisco and networking with colleagues from around the world.
With the days’ events starting at 7:30 a.m., you’ll need to set your alarm clocks a little earlier at ENDO 2013. Plenary sessions featuring a number of notable experts will headline the first three days of the meeting:
Steven Kahn will present the Clinical Investigator Award Lecture, highlighting the roles of beta-cells in type 2 diabetes pathogenesis.
In the Gerald D. Aurbach Award Lecture, Mitchell Lazar will explore the influence of circadian epigenomic regulation on metabolism.
Donald McDonnell will examine the estrogen receptor’s mediation of bone and breast pathologies in the Roy O. Greep Award Lecture.
Gary Hammer will present the Edwin B. Astwood Award Lecture on the implications of adrenal stem cells for human disease.
Posters and Symposia
ENDO 2013’s innovative design has allowed the addition of the new Featured Poster Presentations, which will take place before the oral sessions from Saturday to Monday. During these events, authors of the top-rated studies from the poster sessions will present their studies, giving just enough background to entice attendees to the posters to find out the results.
Tuesday, June 18, the final day of ENDO 2013, brings a tremendous number of excellent sessions, beginning at 7:30 a.m. with symposia featuring cutting-edge science in areas such as diabetes, tumor biology, and signaling. Clinicians will be interested in the Clinical Practice Guideline session, which will examine current best practices for treatment of diabetes during pregnancy. Th e highly popular Master Clinician series will include a Tuesday afternoon session focused on osteoporosis. Attendees interested in genomics will not want to miss Lynn Jorde’s Year in Genomics nor Peggy Farnham’s Special Scientific Session featuring a hands-on discussion on accessing and using genomic data.
Complementing the Year in GPCRs by Graeme Milligan, Jesse Roth will delve into more than a century of advances in endocrine signaling during the Clark T. Sawin Memorial History of Endocrinology Lecture.
Wait, There’s More
While the main ENDO programing will end at 3 p.m. on Tuesday, the special forum “New Light on GPCRs in the Pathophysiology of Diabetes and Metabolic Disorders” will provide a unique opportunity to hear insights from global experts on the latest research into GPCR structure/ function and roles in metabolic regulation. In addition to a schedule packed with the very best in endocrine research and practice, the San Francisco location of ENDO 2013 ensures that attendees will enjoy fantastic weather and diverse activities. To learn more or to register, visit www.endo-society.org/endo2013.